Enhancement_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
1_CD
replication_NN
in_IN
monocytes_NNS
by_IN
1,25-dihydroxycholecalciferol_NN
._.

Human_JJ
immunodeficiency_NN
virus_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
expression_NN
and_CC
replication_NN
are_VBP
under_IN
tight_JJ
regulatory_JJ
control_NN
._.

We_PRP
demonstrate_VBP
that_IN
1,25-dihydroxycholecalciferol_NN
-LCB-_-LRB-
1,25_CD
-_:
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
-RCB-_-RRB-
enhances_VBZ
the_DT
replication_NN
of_IN
monocyte_NN
-_:
and_CC
lymphocyte-tropic_JJ
strains_NNS
of_IN
HIV-1_NN
up_RP
to_TO
10,000-fold_NN
in_IN
monocyte_NN
cell_NN
lines_NNS
,_,
peripheral_JJ
blood_NN
monocytes_NNS
,_,
and_CC
unfractionated_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
._.

1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
is_VBZ
therefore_RB
one_CD
of_IN
the_DT
most_RBS
potent_JJ
regulators_NNS
of_IN
HIV-1_NN
replication_NN
described_VBN
to_TO
date_NN
._.

Precursors_NNS
of_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
enhance_VBP
HIV-1_NN
replication_NN
in_IN
proportion_NN
to_TO
their_PRP$
affinity_NN
for_IN
the_DT
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
intracellular_JJ
receptor_NN
,_,
suggesting_VBG
that_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
influences_VBZ
HIV-1_NN
replication_NN
by_IN
mechanisms_NNS
involving_VBG
this_DT
receptor_NN
._.

These_DT
studies_NNS
may_MD
have_VB
important_JJ
implications_NNS
for_IN
the_DT
design_NN
of_IN
effective_JJ
therapy_NN
of_IN
HIV-1_NN
infection_NN
._.

